Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-05-25 Sale | 2022-05-27 7:20 pm | Elevation Oncology Inc. | ELEV | venBio Global Strategic Fund III L.P. VENBIO GLOBAL STRATEGIC GP III L.P. GOODMAN COREY S Adelman Robert J Royston Aaron 10% Owner | 702,737 | $4.1236 | $2,897,806 | 1,905,430 (Direct) | View |
| 2021-10-25 Purchase | 2021-10-25 6:42 pm | Ventyx Biosciences Inc. | VTYX | Royston Aaron Director 10% Owner | 312,500 | $16 | $5,000,000 | 5,011,536 (Indirect) | View |
| 2021-06-29 Purchase | 2021-07-01 5:27 pm | Elevation Oncology Inc. | ELEV | venBio Global Strategic Fund III L.P. VENBIO GLOBAL STRATEGIC GP III L.P. GOODMAN COREY S Adelman Robert J Royston Aaron 10% Owner | 625,000 | $16 | $10,000,000 | 2,608,167 (Direct) | View |
| 2019-06-24 Purchase | 2019-06-25 6:05 pm | Akero Therapeutics Inc. | AKRO | Royston Aaron Director | 250,000 | $16 | $4,000,000 | 3,954,858 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-06-09 Option Award(A) | 2023-04-26 8:31 pm | N/A 2032-06-09 | Ventyx Biosciences Inc. | VTYX | Royston Aaron Director | 21,825 | $0 | 21,825 (Direct) | View |
| 2022-06-09 Option Award | 2022-06-10 5:42 pm | N/A 2032-06-09 | Ventyx Biosciences Inc. | VTYX | Royston Aaron Director | 13,301 | $0 | 13,301 (Direct) | View |
| 2021-10-25 Conversion | 2021-10-25 6:42 pm | N/A N/A | Ventyx Biosciences Inc. | VTYX | Royston Aaron Director 10% Owner | 7,369,538 | $0 | 5,011,536 (Indirect) | View |
Ownership | 2021-10-20 6:41 pm | N/A N/A | Ventyx Biosciences Inc. | VTYX | Royston Aaron Director 10% Owner | 0 | $0 | 4,699,036 (Indirect) | View |
| 2021-06-29 Conversion | 2021-07-01 5:27 pm | N/A N/A | Elevation Oncology Inc. | ELEV | venBio Global Strategic Fund III L.P. VENBIO GLOBAL STRATEGIC GP III L.P. GOODMAN COREY S Adelman Robert J Royston Aaron 10% Owner | 10,363,201 | $0 | 2,608,167 (Direct) | View |
Ownership | 2021-06-24 6:03 pm | N/A N/A | Elevation Oncology Inc. | ELEV | venBio Global Strategic Fund III L.P. VENBIO GLOBAL STRATEGIC GP III L.P. VENBIO GLOBAL STRATEGIC GP III LTD Adelman Robert J GOODMAN COREY S Royston Aaron 10% Owner | 0 | $0 | 1,983,167 (Direct) | View |
| 2019-06-25 Option Award(A) | 2019-08-08 9:24 pm | N/A 2029-06-25 | Menlo Therapeutics Inc. | MNLO | Royston Aaron Director | 22,500 | $0 | 22,500 (Direct) | View |
| 2019-06-25 Option Award | 2019-06-27 4:18 pm | N/A 2029-06-25 | Menlo Therapeutics Inc. | MNLO | Royston Aaron Director | 22,500 | $0 | 22,500 (Direct) | View |
| 2019-06-24 Conversion | 2019-06-25 6:05 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | Royston Aaron Director | 15,094,262 | $0 | 3,954,858 (Indirect) | View |
Ownership | 2019-06-19 6:30 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | Royston Aaron Director | 0 | $0 | 3,704,858 (Indirect) | View |